Stocktoria
ABVC BIOPHARMA, INC. ABVC
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2004-11-09
ABVC BIOPHARMA, INC. statistics & valuation
Market cap$39.8M
P / B3.0×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | — | 99.9% | -98.1% | 70.5% | 98.6% |
| Operating margin | -2416.0% | -923.3% | -4439.2% | -1558.5% | -3290.1% |
| Net margin | -2671.8% | -962.1% | -5109.3% | -1693.5% | -3608.5% |
| FCF margin | — | — | -2760.6% | -775.2% | -2140.3% |
| Return on assets | -37.5% | -65.0% | -100.0% | -171.4% | -93.7% |
| Return on equity | -59.5% | -399.9% | -501.1% | -507.5% | -144.7% |
| Current ratio | 0.41 | 0.33 | 0.27 | 0.54 | 2.07 |
| Revenue growth | -41.9% | 234.3% | -84.3% | 172.6% | -26.3% |
Source: SEC EDGAR filings · CIK 0001173313 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.